Zhejiang Wecome Pharmaceutical Company Limited
SHZ: 300878.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Xiaoxia Kong
- Employees
- 1,159
- Headquarters
- Lishui, China
- IPO year
- 2020
- Market cap
- CN¥4.5B
- Website
- https://www.zjwk.com
Loading 300878…
Loading profile data…Frequently asked questions about 300878
What does Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) do?
Zhejiang Wecome Pharmaceutical Company Limited engages in the research and development, production, and sale of pharmaceutical products. The company also offers healthcare products, over-the-counter products, and Chinese medicines. It offers products in various forms, including hard capsules, tablets, granules, soft capsules, pills, and other do...
Where does 300878.SZ trade?
Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300878.SZ in?
Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zhejiang Wecome Pharmaceutical Company Limited?
Xiaoxia Kong is the chief executive officer of Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ).
Where is Zhejiang Wecome Pharmaceutical Company Limited headquartered?
Zhejiang Wecome Pharmaceutical Company Limited is headquartered in China.
Does 300878.SZ pay a dividend?
Yes — Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300878.SZ go public?
Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ) completed its initial public offering in 2020.